Seminars in Nuclear Medicine
Volume 39, Issue 2 , Pages 81-87 , March 2009

Fever of Unknown Origin

  • Chantal P. Bleeker-Rovers, MD, PhD

      Affiliations

    • Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
    • Nijmegen Institute for Infection, Inflammation and Immunity (N4I), Nijmegen, the Netherlands
    • Corresponding Author InformationAddress reprint requests to Chantal P. Bleeker-Rovers, MD, PhD, Department of General Internal Medicine 463, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, the Netherlands
    • ,
  • Jos W.M. van der Meer, MD, PhD

      Affiliations

    • Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
    • Nijmegen Institute for Infection, Inflammation and Immunity (N4I), Nijmegen, the Netherlands
    • ,
  • Wim J.G. Oyen, MD, PhD

      Affiliations

    • Nijmegen Institute for Infection, Inflammation and Immunity (N4I), Nijmegen, the Netherlands
    • Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

References 

  1. Petersdorf RG, Beeson PB. Fever of unexplained origin: Report on 100 cases. Medicine. 1961;40:1–30
  2. Bleeker-Rovers CP, Vos FJ, de Kleijn EM, et al. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007;86:26–38
  3. Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med. 2003;253:263–275
  4. Petersdorf RG. Fever of unknown origin (An old friend revisited). Arch Intern Med. 1992;152:21–22
  5. Weiner R. The role of transferrin and other receptors in the mechanism of 67Ga localization. Int J Rad Appl Instrum B. 1990;17:141–149
  6. Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med. 1994;24:128–141
  7. Perkins PJ. Early gallium-67 abdominal imaging: Pitfalls due to bowel activity. AJR Am J Roentgenol. 1981;136:1016–1017
  8. Bekerman C, Hoffer PB, Bitran JD. The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med. 1984;14:296–323
  9. Knockaert DC, Mortelmans LA, De Roo MC, et al. Clinical value of gallium-67 scintigraphy in evaluation of fever of unknown origin. Clin Infect Dis. 1994;18:601–605
  10. Syrjala MT, Valtonen V, Liewendahl K, et al. Diagnostic significance of indium-111 granulocyte scintigraphy in febrile patients. J Nucl Med. 1987;28:155–160
  11. Schmidt KG, Rasmussen JW, Sorensen PG, et al. Indium-111-granulocyte scintigraphy in the evaluation of patients with fever of undetermined origin. Scand J Infect Dis. 1987;19:339–345
  12. MacSweeney JE, Peters AM, Lavender JP. Indium labelled leucocyte scanning in pyrexia of unknown origin. Clin Radiol. 1990;42:414–417
  13. Kjaer A, Lebech AM. Diagnostic value of (111)In-granulocyte scintigraphy in patients with fever of unknown origin. J Nucl Med. 2002;43:140–144
  14. Kjaer A, Lebech AM, Eigtved A, et al. Fever of unknown origin: Prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004;31:622–626
  15. Schell-Frederick E, Fruhling J, Van der Auwera P, et al. 111Indium-oxine-labeled leukocytes in the diagnosis of localized infection in patients with neoplastic disease. Cancer. 1984;54:817–824
  16. Becker W, Goldenberg DM, Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Semin Nucl Med. 1994;24:142–153
  17. Skehan SJ, White JF, Evans JW, et al. Mechanism of accumulation of 99mTc-sulesomab in inflammation. J Nucl Med. 2003;44:11–18
  18. Lipp RW, Wirnsberger GH, Ratschek M, et al. The influence of vascular diathesis on the localization of inflammatory foci in renal allografts with a specific antigranulocyte antibody. Eur J Nucl Med. 1996;23:395–400
  19. Joseph K, Hoffken H, Bosslet K, et al. In vivo labelling of granulocytes with 99mTc anti-NCA monoclonal antibodies for imaging inflammation. Eur J Nucl Med. 1988;14:367–373
  20. Lind P, Langsteger W, Koltringer P, et al. Immunoscintigraphy of inflammatory processes with a technetium-99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183). J Nucl Med. 1990;31:417–423
  21. Steinstrasser A, Oberhausen E. Granulocyte labelling kit BW 250/183—results of the European multicenter trial. Nuklearmedizin. 1996;35:1–11
  22. Becker W, Dolkemeyer U, Gramatzki M, et al. Use of immunoscintigraphy in the diagnosis of fever of unknown origin. Eur J Nucl Med. 1993;20:1078–1083
  23. Meller J, Ivancevic V, Conrad M, et al. Clinical value of immunoscintigraphy in patients with fever of unknown origin. J Nucl Med. 1998;39:1248–1253
  24. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972–1980
  25. Yamada S, Kubota K, Kubota R, et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301–1306
  26. Sugawara Y, Gutowski TD, Fisher SJ, et al. Uptake of positron emission tomography tracers in experimental bacterial infections: A comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA. Eur J Nucl Med. 1999;26:333–341
  27. Tahara T, Ichiya Y, Kuwabara Y, et al. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: A PET study. J Comput Assist Tomogr. 1989;13:829–831
  28. De Winter F, Vogelaers D, Gemmel F, et al. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis. 2002;21:247–257
  29. Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47–59
  30. de Groot M, Meeuwis AP, Kok PJ, et al. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging. 2005;32:98–101
  31. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35–45
  32. Bleeker-Rovers CP, Boerman OC, Rennen HJ, et al. Radiolabeled compounds in diagnosis of infectious and inflammatory disease. Curr Pharm Des. 2004;10:2935–2950
  33. Meller J, Altenvoerde G, Munzel U, et al. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med. 2000;27:1617–1625
  34. Blockmans D, Stroobants S, Maes A, et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: Evidence for inflammation of the aortic arch. Am J Med. 2000;108:246–249
  35. Blockmans D, Knockaert D, Maes A, et al. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis. 2001;32:191–196
  36. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun. 2001;22:779–783
  37. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29–37
  38. Buysschaert I, Vanderschueren S, Blockmans D, et al. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med. 2004;15:151–156
  39. Federici L, Blondet C, Imperiale A, et al: Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: A single centre analysis experience. Int J Clin Pract 2008 May 7 [Epub ahead of print]
  40. Bleeker-Rovers CP, Vos FJ, Mudde AH, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2007;34:694–703
  41. Jaruskova M, Belohlavek O. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging. 2006;33:913–918

PII: S0001-2998(08)00119-0

doi: 10.1053/j.semnuclmed.2008.10.002

Seminars in Nuclear Medicine
Volume 39, Issue 2 , Pages 81-87 , March 2009

Article Tools

* Image Usage & Resolution